1 |
Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin. 1999; 49:8-31.
DOI
|
2 |
Pak JU, Moon SJ, Moon K, Won JH. J Kor Orient Oncol. 1999;5:137-50.
|
3 |
Hwang DR, Kang YS, Kim SS, Kim DH, Shin MK, Song HJ. Studies on the Allergic asthma effect of Semen Armeniaceae Amarum. Kor J Herbol. 2003;18:201-8.
|
4 |
Fukuta T, Ito H, Mukainaka T, Tokuda H, Nishino H, Yoshida T. Anti-tumor promoting effect of glycosides from Prunus persica seeds. Biol Pharm Bull. 2003;26:271-3.
DOI
|
5 |
Shim BS, Park JK, Choi SH. J Kor Orient Oncol. 2000;6:19-28.
|
6 |
Ellison NM, Byar DP, Newell GR. Special report on Laetrile: the NCI Laetrile Review. Results of the National Cancer Institute's retrospective Laetrile analysis. New Engl J Med. 1978;299:549-52.
DOI
|
7 |
Wyllie AH, Kerr JF, Currie AR. Cell death: the significance ofapoptosis. Int Rev Cytol. 1980;68:251-306.
DOI
|
8 |
Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-19.
DOI
|
9 |
Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1-16.
DOI
|
10 |
Nagata S. Apoptosis by death factor. Cell. 1997;88:355-65.
DOI
|
11 |
Communal C, Sumandea M, de Tombe P, Narula J, Solaro RJ, Hajjar RJ. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U.S.A. 2002;99:6252-6.
DOI
|
12 |
Thompson CB. Apoptosis in the pathogenesis and treatment of diseases. Science. 1995;267: 1456-62.
DOI
|
13 |
Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000;21:485-95.
DOI
|
14 |
Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell. 1994;78:539-42.
DOI
|
15 |
Steller H. Mechanisms and genes of cellular suicide. Science. 1995;267:1445-9.
DOI
|
16 |
Raff MC. Social controls on cell survival and cell death. Nature. 1992;356:397-400.
DOI
|
17 |
Eastman A, Barry MA. The origins of DNA breaks: a consequence of DNA damage, DNA repair or apoptosis? Cancer Invest. 1992; 10:229-40.
DOI
|
18 |
Dive C, Hickman JA. Drug-target interactions; only the first step in the commitment to a programmed cell death? Br J Cancer. 1991;64:192-6.
DOI
|
19 |
Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells. 1990;2:275-80.
|
20 |
Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619-26.
DOI
|
21 |
Tsujimoto Y, Croce CM. Analysis and structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA. 1986; 83:5314-8.
DOI
|
22 |
Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson MM, et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Path. 1993;143:390-400.
|
23 |
McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, et al. Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen-independent prostate cancer. J Urol. 1997;157:569-74.
DOI
|
24 |
McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992;52:6940-4.
|
25 |
Gleave ME, Tolcher A, Miyake H, Nelson C, Brown B, Beraldi E, et al. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model. Clin Cancer Res. 1999;5:2891-8.
|
26 |
Marcelli M, Marani M, Li X, Sturgis L, Haidacher SJ, Trial JA, et al. Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis expression of Bcl-2 family members, and caspase activation. Prostate. 2000;42:260-73.
DOI
|
27 |
Miyake H, Monia BP, Gleave ME. Inhibition of progression to androgen-induced by combine adjuvant treatment with antisense BCL-xL and antisense Bcl-2 oligonucleotide plus Taxol after castration in the shionogi tumor model. Int J Cancer. 2000;86:855-62.
DOI
|
28 |
Du C, Fang M, Li Y, Li L, Wang X. Smac, amitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 2000;102: 33-42.
DOI
|
29 |
Verhagen AM, Ekert PG, Pakusch M. Silke J, Connolly LM, Reid GE, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 2000;102:55-66.
DOI
|
30 |
Lowe SL, Rubinchik S, Honda T, McDonnell TJ, Dong JY, Norris JS. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells. Gene Therapy. 2001;8:1363-71.
DOI
|
31 |
Hoshi T, Sasano H, Kato K, Yabuki N, Ohara S, Konno R, et al. Immunohistochemistry of caspase-3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res. 1998;18:4347-53.
|